Jin Dan, Lu Fu-er, Chen Guang, Sun Huan, Lu Xiao-hong
Institute of Integrated Traditional & Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei Province 430030, China.
Zhong Xi Yi Jie He Xue Bao. 2007 Sep;5(5):541-5. doi: 10.3736/jcim20070513.
To observe the effects of Huanglian Jiedu Decoction (HLJDD), a traditional Chinese compound herbal medicine, on p85 mRNA and protein expressions of phosphatidylinositol-3-kinase (PI-3K) in target tissues (skeletal muscular and adipose tissues) in rats with type 2 diabetes mellitus (T2DM) and to investigate the molecular mechanism of HLJDD in treating T2DM.
The male Wistar rats were injected with streptozotocin (STZ) 30 mg/kg through tail vein, and fed with high-fat and high-caloric diets to induce T2DM. Then the rats were randomly divided into untreated group, aspirin-treated group and HLJDD group, and treated correspondingly. Meanwhile, a group of normal animals without any treatment was set up for normal control group. Ten weeks later, serum fasting blood glucose (FBG), serum fasting insulin (FINS) and oral glucose tolerance test (OGTT) were routinely determined. The expressions of PI-3K p85 mRNA and protein in skeletal muscle and adipose tissue were determined with RT-PCR and Western blotting before and after insulin treatment.
Compared with the untreated group, the FBG and OGTT levels in T2DM rats treated with HLJDD decreased significantly (P<0.05). The FINS in HLJDD group was lower than that in the normal control group (P<0.05), but was not significantly different from that in the untreated group. The PI-3K p85 mRNA and protein expressions in HLJDD group obviously increased, as compared with those in the untreated group.
The effect of HLJDD in treating T2DM was probably associated with its improvement of PI-3K p85 mRNA and protein expressions in skeletal muscle and adipose tissue of the T2DM rats.
观察中药复方黄连解毒汤对2型糖尿病(T2DM)大鼠靶组织(骨骼肌和脂肪组织)中磷脂酰肌醇-3-激酶(PI-3K)的p85 mRNA和蛋白表达的影响,并探讨黄连解毒汤治疗T2DM的分子机制。
雄性Wistar大鼠经尾静脉注射链脲佐菌素(STZ)30 mg/kg,并给予高脂高热量饮食诱导T2DM。然后将大鼠随机分为未治疗组、阿司匹林治疗组和黄连解毒汤组,并进行相应治疗。同时,设立一组未作任何处理的正常动物作为正常对照组。10周后,常规测定血清空腹血糖(FBG)、血清空腹胰岛素(FINS)和口服葡萄糖耐量试验(OGTT)。胰岛素治疗前后,采用RT-PCR和Western印迹法检测骨骼肌和脂肪组织中PI-3K p85 mRNA和蛋白的表达。
与未治疗组相比,黄连解毒汤治疗的T2DM大鼠的FBG和OGTT水平显著降低(P<0.05)。黄连解毒汤组的FINS低于正常对照组(P<0.05),但与未治疗组无显著差异。与未治疗组相比,黄连解毒汤组PI-3K p85 mRNA和蛋白表达明显增加。
黄连解毒汤治疗T2DM的作用可能与其改善T2DM大鼠骨骼肌和脂肪组织中PI-3K p85 mRNA和蛋白表达有关。